ID

24892

Descripción

Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease

Palabras clave

Versiones (2)
  1. 22/8/17 22/8/17 -
  2. 4/9/17 4/9/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

22 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

study medication administration determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

Inglés

study medication administration determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 formularios  
Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Initials
Descripción

patient's initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Patient No.
Descripción

patient number

Tipo de datos

integer

Alias
UMLS CUI [1]
C1830427
Dose#1
Descripción

Dose#1

Alias
UMLS CUI-1
C3174092
Date of Administration
Descripción

date of administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1533734
UMLS CUI [1,2]
C0011008
Time of Administration
Descripción

24-hour clock

Tipo de datos

time

Alias
UMLS CUI [1]
C1317775
Dose#2
Descripción

Dose#2

Alias
UMLS CUI-1
C3174092
Time of Administration
Descripción

24-hour clock

Tipo de datos

time

Alias
UMLS CUI [1]
C1317775
Dose#3
Descripción

Dose#3

Alias
UMLS CUI-1
C3174092
Time of Administration
Descripción

24-hour clock

Tipo de datos

time

Alias
UMLS CUI [1]
C1317775
Volver a la parte superior de la página

Similar models

study medication administration determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
patient's initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
patient number
Item
Patient No.
integer
C1830427 (UMLS CUI [1])
Item Group
Dose#1
C3174092 (UMLS CUI-1)
date of administration
Item
Date of Administration
date
C1533734 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
time of administration
Item
Time of Administration
time
C1317775 (UMLS CUI [1])
Item Group
Dose#2
C3174092 (UMLS CUI-1)
time of administration
Item
Time of Administration
time
C1317775 (UMLS CUI [1])
Item Group
Dose#3
C3174092 (UMLS CUI-1)
time of administration
Item
Time of Administration
time
C1317775 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial